Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 12, 2006, Pages 2546-2548

  Van Der Pols, Jolieke C ^a,b   Williams, Gail M ^a   Pandeya, Nirmala ^b   Logan, Valerie ^b   Green, Adèle C ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ARTICLE; AUSTRALIA; BASAL CELL CARCINOMA; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; FOREARM; HAND; HEAD; HUMAN; MAJOR CLINICAL STUDY; NECK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; SKIN NEOPLASMS; SUNSCREENING AGENTS;

EID: 33846023684     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0352     Document Type: Article

References (13)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Joseph AK, Mark TL, Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 2001;27:955-9.
3. Task Force on Community Preventive Services. Recommendations to prevent skin cancer by reducing exposure to ultraviolet radiation. Am J Prev Med 2004;27:467-70.
4. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003;139:451-5.
5. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999;354:723-9. Erratum: Lancet 1999;354:1038.
6. Pandeya N, Purdie DM, Green A, Williams G. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial. Am J Epidemiol 2005;161:748-54.
7. van der Pols JC, Williams GM, Neale RE, Clavarino A, Green AC. Long-term increase in sunscreen use in an Australian community after a skin cancer prevention trial. Prev Med 2006;42:171-6.
8. Green AC, Williams GM, Neale RE, Battistutta D. Beta-carotene and sunscreen use: authors' reply. Lancet 1999;354:2163-4.
9. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165-8.
10. Sollitto RB, Kraemer KH, DiGiovanna JJ. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J Am Acad Dermatol 1997;37:942-7.
11. Farrerons J, Barnadas M, Rodriguez J, et al. Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. Br J Dermatol 1998;139:422-7.
12. Autier P, Dore JF, Negrier S, et al. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 1999;91:1304-9.
13. Dupuy A, Dunant A, Grob JJ. Randomized controlled trial testing the impact of high-protection sunscreens on sun-exposure behavior. Arch Dermatol 2005;141:950-6.